Paul Petrelli is a respected leader in the Canadian biotech industry with a proven track record of commercial excellence, a focus on supporting high performing culture and people development, and experience leading teams in diverse markets including in Canada, Europe, and the US. He brings 20+ years of expertise across nearly every aspect of the pharmaceutical sector, including product lifecycle management and a deep understanding of sales, marketing, market access, medical, government relations, regulatory and more.
Prior to joining Gilead Canada, Paul most recently led Jazz Pharmaceuticals, where he built their Canadian organization over the past 7 years. His prior commercial experience also includes increasingly senior commercial roles at GSK, AstraZeneca and Biogen.
Day 1 Oct 28, 2025
10:20 am
C-SUITE PANEL
Identifying Industry Risks and Opportunities in an Evolving Canadian Environment
The landscape of market access for pharmaceutical and healthcare is rapidly changing, presenting both pitfalls and opportunities for the industry to meet patient needs. Understanding key risks and proactively identifying growth opportunities is essential for long-term success. Develop a blueprint to:
- Assess the impact of regulatory changes and explore how the industry can engage effectively with regulators.
- Identify emerging opportunities for growth and innovation and examine how they can enhance patient access.
- Develop strategies to mitigate risks and capitalize on key trends by leveraging data-driven insights, stakeholder collaboration, and adaptive business models.
Bolster your ability to navigate a dynamic pharmaceutical environment to identify emerging opportunities, mitigate evolving risks, and strengthen patient access across Canada.
Day 2 Oct 29, 2025
